Regeneron Pharmaceuticals logo

Scientist, Radioconjugation

Regeneron Pharmaceuticals

Tarrytown, NYOnsitePosted 2 days ago$95,800.00 - $156,400.00
Full TimeSenior LevelResearch & ScientistBiotechnology
Original posting ↗

Summary

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. As a Scientist in Therapeutic Proteins - Antibody Radioconjugates Technology, you will play a critical role in advancing preclinical imaging and radiotherapeutic programs across multiple therapeutic areas. You will independently design, execute, and improve antibody bioconjugation and radiolabeling workflows, generating high-quality imaging and therapeutic tracers that enable quantitative evaluation of candidate therapies. Your expertise will directly support studies in Oncology, Immuno-Oncology, Infectious Disease, Inflammation, Metabolic Disease, and beyond, helping scientists better understand biodistribution, target engagement, pharmacokinetics, and therapeutic potential.

Job description

Build our future together

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. As a Scientist in Therapeutic Proteins - Antibody Radioconjugates Technology, you will play a critical role in advancing preclinical imaging and radiotherapeutic programs across multiple therapeutic areas. You will independently design, execute, and improve antibody bioconjugation and radiolabeling workflows, generating high-quality imaging and therapeutic tracers that enable quantitative evaluation of candidate therapies. Your expertise will directly support studies in Oncology, Immuno-Oncology, Infectious Disease, Inflammation, Metabolic Disease, and beyond, helping scientists better understand biodistribution, target engagement, pharmacokinetics, and therapeutic potential.

When & where

  • Location: Tarrytown, NY
  • Work Model: On-site 5 days per week

Discover your role

  • Lead the planning and execution of antibody bioconjugation and radiolabeling campaigns to support preclinical imaging and therapeutic studies.
  • Perform conjugation of antibodies and alternative antibody formats with bifunctional chelating agents and fluorescent probes.
  • Develop, optimize, qualify, and document novel conjugation and radiolabeling methods for new chelators and radionuclides.
  • Characterize bioconjugates using analytical techniques including SE-HPLC, SDS-PAGE, Western blotting, and UV/Vis spectroscopy.
  • Generate and purify radiolabeled therapeutics and imaging tracers using radionuclides such as Cu-64, Zr-89, Lu-177, and Ac-225.
  • Own product quality control, release testing, data interpretation, and root cause investigations for out-of-trend results.
  • Design and execute cell-based assays to evaluate binding, potency, cytotoxicity, and mechanism of action for radioconjugate candidates.
  • Collaborate with imaging scientists and cross-functional project teams while leading technical initiatives, maintaining compliance records, and mentoring colleagues on specialized laboratory methods.

This role requires

  • B.S. or M.S. in Chemistry, Radiochemistry, Biochemistry, Chemical Engineering, Chemical Biology, or a related scientific discipline.
  • M.S. with 4-6 years of relevant industry laboratory experience, or B.S. with 7-9 years of relevant industry laboratory experience.
  • Willingness and ability to qualify as an authorized radiation worker.
  • Demonstrated hands-on expertise in protein chemistry, bioconjugation, and chromatographic separations, including independent method development or qualification experience.
  • Experience working with radioactive materials in a research, radiopharmacy, nuclear medicine, or similar regulated laboratory environment is preferred.
  • Experience with radiation detection and radioanalytical methods, including radio-HPLC, radio-iTLC, and gamma counting is preferred.
  • Experience with flow cytometry.
  • Proficiency with data analysis software, including Excel, Prism, or similar tools, and electronic laboratory notebook systems.
  • Strong communication skills and the ability to work independently while supporting cross-functional teams in a fast-paced environment.

Requirements

  • B.S. or M.S. in Chemistry, Radiochemistry, Biochemistry, Chemical Engineering, Chemical Biology, or a related scientific discipline
  • M.S. with 4-6 years of relevant industry laboratory experience, or B.S. with 7-9 years of relevant industry laboratory experience
  • Willingness and ability to qualify as an authorized radiation worker
  • Demonstrated hands-on expertise in protein chemistry, bioconjugation, and chromatographic separations, including independent method development or qualification experience
  • Experience working with radioactive materials in a research, radiopharmacy, nuclear medicine, or similar regulated laboratory environment is preferred
  • Experience with radiation detection and radioanalytical methods, including radio-HPLC, radio-iTLC, and gamma counting is preferred
  • Experience with flow cytometry
  • Proficiency with data analysis software, including Excel, Prism, or similar tools, and electronic laboratory notebook systems
  • Strong communication skills and the ability to work independently while supporting cross-functional teams in a fast-paced environment

Benefits

  • Annual bonuses
  • Incentive plans
  • Equity awards
  • Pension or retirement benefits
  • 401(k) company match
  • Health and wellness programs
  • Fitness centers
  • Medical, Dental & Vision
  • Life and disability insurance
  • Paid time off
  • Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.